Xinglin Li
Beijing Key Laboratory Of Emerging Infectious Diseases
Beijing, 100015, China
Beijing, 100015, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Antibody Responses After BA.5/BF.7 Breakthrough Infection in People Living with HIV.
Journal: Vaccines
Published: February 15, 2026
The development and application of cleavage under targets and tagmentation (CUT&Tag) technology.
Journal: Journal of biological methods
Published: June 19, 2024
Characterization of CCoV-HuPn-2018 spike protein-mediated viral entry.
Journal: Journal of virology
Published: September 07, 2023
Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac plus one dose subunit vaccine.
Journal: Journal of medical virology
Published: June 13, 2023
Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development.
Journal: Journal of molecular biology
Published: December 03, 2021
Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion.
Journal: Emerging microbes & infections
Published: July 01, 2020
Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Journal: Journal of virology
Published: May 13, 2020
LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
Journal: Journal of virology
Published: March 30, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026